Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levels

European Journal of Endocrinology

Volumn 153, Issue 2, 2005, Pages 283-290

  Valtueña, Silvia ^b   Numeroso, Filippo ^b   Ardigò, Diego ^b   Pedrazzoni, Mario ^b   Franzini, Laura ^b   Piatti, Pier Marco ^a   Monti, Lucilla ^a   Zavaroni, Ivana ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; GLUCOSE; INSULIN; LEPTIN; LIPID; URIC ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FATTY LIVER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; POSTMENOPAUSE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

AGED; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BODY COMPOSITION; FASTING; FATTY LIVER; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; RISK FACTORS; TRANSAMINASES;

EID: 23844514140     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01960     Document Type: Article

References (38)

1. Marchesini G & Forlani G. NASH: From liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 2002 35 497-499.
2. Caldwell SH, Oelsner DH, Iezzoni JC, Hespheneide EE, Battle EH & Driscoll CJ. Cryptogenenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999 29 664-669.
3. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, Antonini TM & Alessandri C. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. Journal of Gastroenterology and Hepatology 2003 18 1115-1117.
4. Browning JD & Horton JD. Molecular mediators of hepatic steatosis and liver injury. Journal of Clinical Investigation 2004 114 147-152.
5. Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L & Bolondi L. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004 53 1020-1023.
6. Cohen P & Friedman JM. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). Journal of Nutrition 2004 134 2455S-2463S.
7. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P & Shulman GI. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation 2002 109 1345-1350.
8. Moran SA, Patten N, Young JR, Cochran E, Sebring N, Reynolds J, Premkumar A, Depaoli AM, Skarulis MC, Oral EA & Gorden P. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. Metabolism 2004 53 513-519.
9. Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N & Dagalp K. Serum leptin levels in patients with nonalcoholic steatohepatitis. American Journal of Gastroenterology 2000 95 3584-3589.
10. Comlekci A, Akpinar H, Yesil S, Okan I, Ellidokuz E, Okan A, Ersoz G, Tankurt E & Batur Y. Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis. Scandinavian Journal of Gastroenterology 2003 38 779-786.
11. Romero-Gomez M, Castellano-Megias VM, Grande L, Irles JA, Cruz M, Nogales MC, Alcon JC & Robles A. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. American Journal of Gastroenterology 2003 98 1135-1141.
12. Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK & Considine RV. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? American Journal of Gastroenterology 2003 98 2771-2776.
13. Perseghin G. Pathogenesis of obesity and diabetes mellitus: insights provided by indirect calorimetry in humans. Acta Diabetologica 2001 38 7-21.
14. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G & Diehl AM. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nature Medicine 2000 6 998-1003.
15. Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore J, Morawiecki A, Boyko EJ & Porte D Jr. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care 1997 20 1476-1481.
16. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL & Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. European Journal of Endocrinology 2003 149 331-335.
17. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q & Garvey WT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. Journal of Clinical Endocrinology and Metabolism 1997 82 1293-1300.
18. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH & Kahn SE. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002 51 1005-1015.
19. Fernandez-Real JM, Casamitjana R & Ricart-Engel W, Leptin is involved in gender-related differences in insulin sensitivity. Clinical Endocrinology 1998 49 505-511.
20. Fernandez-Real JM, Vayreda M, Casamitjana R, Gonzalez-Huix F & Ricart W. The fat-free mass compartment influences serum leptin in men. European Journal of Endocrinology 2000 142 25-29.
21. Garcia-Lorda P, Bullo M, Vila R, del Mar Grasa M, Alemany M & Salas-Salvado J. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females. Diabetes, Nutrition and Metabolism 2001 14 329-336.
22. Alberti KG & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Medicine 1998 15 539-553.
23. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, Horlick M, Kotler D, Laferrere B, Mayer L, Pi-Sunyer FX & Pierson RN Jr. Comparisons of waist circumferences measured at 4 sites. American Journal of Clinical Nutrition 2003 77 379-384.
24. Saverymuttu SH, Joseph AEA & Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. British Medical Journal 1986 292 13-15.
25. Ravussin E & Bogardus C. Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. American Journal of Clinical Nutrition 1989 49 968-975.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
27. Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall'Aglio E, Delsignore R & Reaven GM. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism 1999 48 989-994.
28. Huang KC, Lin RC, Kormas N, Lee LT, Chen CY, Gill TP & Caterson ID. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents. International Journal of Obesity and Related Metabolic Disorders 2004 28 470-475.
29. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G & Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. American Journal of Medicine 1999 107 450-455.
30. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P & Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002 35 367-372.
31. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferranini E & Pizzetto M. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005 48 634-642.
32. Nicolas JM, Fernandez-Sola J, Fatjo F, Casamitjana R, Bataller R, Scanella E, Tobias E, Badia E & Estruch R. Increased circulating leptin levels in chronic alcoholism. Alcoholism, Clinical and Experimental Research 2001 25 83-88.
33. Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D & George J. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002 36 403-409.
34. Serin E, Ozer B, Gumurdulu Y, Kayaselcuk F, Kul K & Boyacioglu S. Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver. Journal of Gastroenterology 2003 38 471-476.
35. Hickman IJ, Powell EE, Prins JB, Clouston AD, Ash S, Purdie DM & Jonsson JR. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. Journal of Hepatology 2003 39 1042-1048.
36. Testa R, Franceschini R, Giannini E, Cataldi A, Botta F, Fasoli A, Tenerelli P, Rolandi E & Barreca T. Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. Journal of Hepatology 2000 33 33-37.
37. Fruehwald-Schultes B, Oltmanns KM, Toschek B, Sopke S, Kern W, Born J, Fehm HL & Peters A. Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men. Metabolism 2002 51 531-536.
38. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Calastra S & Ferranini E. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002 51 144-151.